Clinical Trial Update: PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava Interruption [Phase 4]

View source ↗

Summary

PREPIC 2 is a Phase 4 trial examining whether vena cava interruption with an inferior vena cava filter can prevent recurrent pulmonary embolism. The study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism
• Venous Thrombosis

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Pulmonary Embolism, Venous Thrombosis | Phase 4 | Status: COMPLETED